Ritlecitinib for Severe Alopecia Areata: A 24-Week, Multicentre, Real-World Study.

Starace M, Rapparini L, Pampaloni F, Cedirian S, Quadrelli F, Bruni F, Martelli G, Girolomoni G, Bellinato F, Gisondi P, Gallo G, Ribero S, Ortoncelli M, Quaglino P, Gargiulo L, Vignoli C, Narcisi A, Ambrogio F, Foti C, Caposiena Caro RD, Zalaudek I, Marzano AV, Sechi A, Barbareschi M, Valtellini L, Ferrucci SM, Diluvio L, Matteini E, Bianchi L, Cantelli M, Nappa P, D'Elia C, Boccaletti V, Romanò C, Fulgione E, Balato A, Argenziano G, Trovato E, Cinotti E, Rubegni P, Dall'Oglio F, Lacarrubba F, Micali G, Pezzolo E, Caroppo F, Belloni Fortina A, Caldarola G, Peris K, Pinto LM, Pagliarello C, Balestri R, Tomasini C, Barruscotti S, Atzori L, Sanna S, Ala L, Bortone G, Pellacani G, Rossi A, Lembo S, Raimondo A, Manzo Margiotta F, Dini V, Romanelli M, Megna A, Prignano F, Silvi G, Simonetti O, De Simoni E, Magnano M, Schettini N, Borghi A, Satolli F, de Felici Del Giudice MB, Rongioletti F, Guida S, Bigotto GD, Filippeschi C, Oranges T, Tronconi G, Piraccini BM

Open source

DOI: 10.1007/s40257-026-01022-5
Published: 2026 May
Container: American journal of clinical dermatology
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1007/s40257-026-01022-5,
  title = {Ritlecitinib for Severe Alopecia Areata: A 24-Week, Multicentre, Real-World Study.},
  author = {Starace M and Rapparini L and Pampaloni F and Cedirian S and Quadrelli F and Bruni F and Martelli G and Girolomoni G and Bellinato F and Gisondi P and Gallo G and Ribero S and Ortoncelli M and Quaglino P and Gargiulo L and Vignoli C and Narcisi A and Ambrogio F and Foti C and Caposiena Caro RD and Zalaudek I and Marzano AV and Sechi A and Barbareschi M and Valtellini L and Ferrucci SM and Diluvio L and Matteini E and Bianchi L and Cantelli M and Nappa P and D'Elia C and Boccaletti V and Romanò C and Fulgione E and Balato A and Argenziano G and Trovato E and Cinotti E and Rubegni P and Dall'Oglio F and Lacarrubba F and Micali G and Pezzolo E and Caroppo F and Belloni Fortina A and Caldarola G and Peris K and Pinto LM and Pagliarello C and Balestri R and Tomasini C and Barruscotti S and Atzori L and Sanna S and Ala L and Bortone G and Pellacani G and Rossi A and Lembo S and Raimondo A and Manzo Margiotta F and Dini V and Romanelli M and Megna A and Prignano F and Silvi G and Simonetti O and De Simoni E and Magnano M and Schettini N and Borghi A and Satolli F and de Felici Del Giudice MB and Rongioletti F and Guida S and Bigotto GD and Filippeschi C and Oranges T and Tronconi G and Piraccini BM},
  year = {2026},
  journal = {American journal of clinical dermatology},
  doi = {10.1007/s40257-026-01022-5},
  url = {https://doi.org/10.1007/s40257-026-01022-5}
}

RIS

TY  - JOUR
TI  - Ritlecitinib for Severe Alopecia Areata: A 24-Week, Multicentre, Real-World Study.
AU  - Starace M
AU  - Rapparini L
AU  - Pampaloni F
AU  - Cedirian S
AU  - Quadrelli F
AU  - Bruni F
AU  - Martelli G
AU  - Girolomoni G
AU  - Bellinato F
AU  - Gisondi P
AU  - Gallo G
AU  - Ribero S
AU  - Ortoncelli M
AU  - Quaglino P
AU  - Gargiulo L
AU  - Vignoli C
AU  - Narcisi A
AU  - Ambrogio F
AU  - Foti C
AU  - Caposiena Caro RD
AU  - Zalaudek I
AU  - Marzano AV
AU  - Sechi A
AU  - Barbareschi M
AU  - Valtellini L
AU  - Ferrucci SM
AU  - Diluvio L
AU  - Matteini E
AU  - Bianchi L
AU  - Cantelli M
AU  - Nappa P
AU  - D'Elia C
AU  - Boccaletti V
AU  - Romanò C
AU  - Fulgione E
AU  - Balato A
AU  - Argenziano G
AU  - Trovato E
AU  - Cinotti E
AU  - Rubegni P
AU  - Dall'Oglio F
AU  - Lacarrubba F
AU  - Micali G
AU  - Pezzolo E
AU  - Caroppo F
AU  - Belloni Fortina A
AU  - Caldarola G
AU  - Peris K
AU  - Pinto LM
AU  - Pagliarello C
AU  - Balestri R
AU  - Tomasini C
AU  - Barruscotti S
AU  - Atzori L
AU  - Sanna S
AU  - Ala L
AU  - Bortone G
AU  - Pellacani G
AU  - Rossi A
AU  - Lembo S
AU  - Raimondo A
AU  - Manzo Margiotta F
AU  - Dini V
AU  - Romanelli M
AU  - Megna A
AU  - Prignano F
AU  - Silvi G
AU  - Simonetti O
AU  - De Simoni E
AU  - Magnano M
AU  - Schettini N
AU  - Borghi A
AU  - Satolli F
AU  - de Felici Del Giudice MB
AU  - Rongioletti F
AU  - Guida S
AU  - Bigotto GD
AU  - Filippeschi C
AU  - Oranges T
AU  - Tronconi G
AU  - Piraccini BM
PY  - 2026
JO  - American journal of clinical dermatology
DO  - 10.1007/s40257-026-01022-5
UR  - https://doi.org/10.1007/s40257-026-01022-5
ER  -

APA

M, S., L, R., F, P., S, C., F, Q., F, B., G, M., G, G., F, B., P, G., G, G., S, R., M, O., P, Q., L, G., C, V., A, N., F, A., C, F., RD, C. C., I, Z., AV, M., A, S., M, B., L, V., SM, F., L, D., E, M., L, B., M, C., P, N., C, D., V, B., C, R., E, F., A, B., G, A., E, T., E, C., P, R., F, D., F, L., G, M., E, P., F, C., A, B. F., G, C., K, P., LM, P., C, P., R, B., C, T., S, B., L, A., S, S., L, A., G, B., G, P., A, R., S, L., A, R., F, M. M., V, D., M, R., A, M., F, P., G, S., O, S., E, D. S., M, M., N, S., A, B., F, S., MB, D. F. D. G., F, R., S, G., GD, B., C, F., T, O., G, T., & BM, P. (2026). Ritlecitinib for Severe Alopecia Areata: A 24-Week, Multicentre, Real-World Study.. American journal of clinical dermatology. https://doi.org/10.1007/s40257-026-01022-5

Source records

pubmed · retrieved 2026-09-25T11:49:13.680Z